Friday 16 October 2026 Export ADCT’s income statement to Excel — free account

ADC Therapeutics SA

ADC Therapeutics SA’s revenue for fiscal 2025 (year ended December 2025) was $81.4 million, up 14.9% from fiscal 2024. In the quarter to June 2026, revenue grew 2.17%, EPS grew 78.0%, free cash flow grew 51.0% and total debt rose 1.87%, each against the same quarter a year earlier.

1.41 0.08 −5.37%

Follow ADCT

Alert me

Market cap: $190.2M
P/E: 0.0×
Fwd P/E: −1.2×
Dividend yield: —
F-score: 5/9
Altman Z: −6.67
Beneish M: −2.09
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	0.00	0.00	0.00	0.00	+8 more quarters Free account
P/S ratio Full definition →	2.08	7.30	5.51	7.26
P/FCF ratio Full definition →	0.00	0.00	0.00	0.00
P/Operating CF Full definition →	(14.05)	(19.46)	(14.41)	(18.42)
P/B ratio Full definition →	0.00	0.00	0.00	0.00
Price to Tangible BV Full definition →	0.00	0.00	0.00	0.00
EV/Sales Full definition →	0.80	5.84	3.72	5.86
EV/EBITDA Full definition →	0.00	0.00	0.00	0.00
EV/Operating CF Full definition →	(0.62)	(4.04)	(2.14)	(3.34)
EV/FCF Full definition →	(0.62)	(4.06)	(2.15)	(3.33)
Quick Ratio Full definition →	2.86	3.87	4.14	4.15
Current Ratio Full definition →	3.03	4.09	4.37	4.63
Net Debt/EBITDA Full definition →	4.03	4.59	8.19	3.86
Debt/Assets Full definition →	41.74%	39.68%	35.73%	39.76%
Debt/Equity Full definition →	(0.51)	(0.53)	(0.62)	(0.48)
Asset Turnover Full definition →	0.26	0.28	0.25	0.24
Operating CF/Net income Full definition →	0.71	0.90	4.86	0.72
Capex/Depreciation Full definition →	0.00	(0.28)	5.83	0.00
Interest Coverage Full definition →	(1.88)	(2.04)	(1.38)	(2.31)
Research and Development Expense of Revenue Full definition →	90.22%	95.33%	78.86%	163.16%
Selling, General and Administrative Expense of Revenue Full definition →	115.72%	108.41%	92.99%	115.75%
Intangible Assets out of Total Assets Full definition →	0.00	0.00	0.00	0.00
Share Based Compensation of Revenue Full definition →	23.64%	11.71%	2.92%	12.18%
Graham Net Nets Full definition →	(1.48)	(0.40)	(0.45)	(0.44)
Graham Number Full definition →	4.68	5.76	6.28	7.55
Earnings Yield Full definition →	(61.68%)	(28.00%)	(33.99%)	(36.25%)
Free Cash Flow Yield Full definition →	(61.32%)	(19.72%)	(31.40%)	(24.25%)
Revenue per Share Full definition →	0.12	0.14	0.18	0.12
Operating CF per Share Full definition →	(0.08)	(0.19)	(0.24)	(0.22)
Capex per Share Full definition →	0.00	0.00	0.01	0.00
Free Cash Flow per Share Full definition →	(0.08)	(0.19)	(0.24)	(0.22)
Cash per Share Full definition →	1.41	1.50	2.06	1.72
Shareholders Equity per Share Full definition →	(1.47)	(1.40)	(1.46)	(1.75)
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	(1.47)	(1.40)	(1.46)	(1.75)
Free Cash Flow Full definition →	(11.81)	(29.74)	(30.46)	(29.63)
Working Capital Full definition →	175.38	209.14	236.17	225.11
Capital Expenditures Full definition →	0.00	(0.03)	0.66	0.00
Net Current Asset Value Full definition →	(245.88)	(231.10)	(202.65)	(240.79)
EV/EBIT Full definition →	0.00	0.00	0.00	0.00
Capex to Sales Full definition →	0.00	0.00	(0.03)	0.00
Price to Operating Income Full definition →	0.00	0.00	0.00	0.00
Other line items
Average Receivables Full definition →	27.11	31.40	24.72	23.47
Average Payables Full definition →	11.19	10.44	13.60	11.25
Average Inventory Full definition →	11.35	11.11	3.22	17.06
Average Assets Full definition →	300.47	282.02	322.57	319.42
Average Common Equity Full definition →	(213.69)	(227.30)	(194.24)	(205.06)

Fold the line items

Columns are period end dates

Stockrow Weekly